Results 11 to 20 of about 3,493 (205)
The USA has a long-standing paediatric influenza vaccination programme, including use of live attenuated influenza vaccine (LAIV). Following US evidence of apparent lack of vaccine effectiveness (VE) of LAIV in 2015/2016, particularly against A(H1N1)pdm09, the USA suspended the use of LAIV in the 2016/2017 season. The UK introduced LAIV for children in
Richard, Pebody +2 more
core +4 more sources
Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity [PDF]
During the previous influenza seasons, between 2010 and 2016, the live attenuated influenza vaccine (LAIV) provided variable efficacy against influenza in the U.S., causing the recommendation against the use of the LAIV. In striking contrast, pre-clinical studies have repeatedly demonstrated superior efficacy of LAIV against mismatched influenza ...
Roy, Sreeja +3 more
openaire +6 more sources
Laiv - Et mulig virkemiddel i historieundervisningen [PDF]
Denne oppgaven handler om oppøving av den historiefaglige empatiferdigheten gjennom deltakelse på laiv, levende rollespill, og om det å lage laiv for en skoleklasse. Oppgaven er historiedidaktisk og jeg beskriver empatiferdigheten, og hva laiv er. Jeg beskriver gjennomføringen av to laiver, en liten og en større, og oppgavene elevene svarte på før og ...
Andersen, Marit Styx
openaire +2 more sources
Introduction Circulating influenza strains, vaccine effectiveness (VE), and vaccine recommendations vary over time. A systematic literature review (SLR), random effects meta-analysis (REMA), and network meta-analysis (NMA) estimated absolute VE (aVE) and
Wilhelmine Meeraus
exaly +3 more sources
Reverse Genetics of Influenza B and the Development of a Novel LAIV Vaccine [PDF]
Due to the disease burden of influenza virus types A and B, vaccines, which are manufactured as formalin-inactivated killed virus (KV) and live-attenuated virus (LAIV), are produced to provide coverage against currently circulating influenza A (IAV) and B (IBV) viruses.
Finch, Courtney LaPaglia
openaire +3 more sources
The development of an influenza vaccine with broad protection and durability remains an attractive idea due to the high mutation rate of the influenza virus.
Daria Mezhenskaya +10 more
doaj +1 more source
TRUEDOP – A NEW QUALITY STEP FOR OFFICIAL ORTHOPHOTOS [PDF]
The National Mapping Agencies (NMA) of the German federal states derive nationwide digital orthophotos with a ground resolution of 10 to 20 cm by aerial surveys at regular cycles of two or three years.
S. Baltrusch
doaj +1 more source
This dataset is the complete data for the two-year LAIV efficacy trial conducted by AIIMS ND-CDC team at Ballabgarh, Dist Faridabad, Haryana. It has three sets of files - first one baseline demographic characteristic of study children and other two being
Krishnan, A (via Mendeley Data)
core +2 more sources
Influenza and S. pneumoniae infections are a significant cause of morbidity and mortality worldwide. Intranasal live influenza vaccine (LAIV) may prevent influenza-related bacterial complications.
Yulia Desheva +7 more
doaj +1 more source
We previously developed a temperature-sensitive, and NS1 gene deleted live attenuated influenza vaccine (DelNS1-LAIV) and demonstrated its potent protective efficacy in intranasally vaccinated mice.
Andrew Chak-Yiu Lee +12 more
doaj +1 more source

